MAb 376.96 is another anti-CD276 monoclonal antibody that recognizes the expression of CD276 epitopes on differentiated ovarian cancer cells and chemotherapy-resistant cancer cells (78). This evidence concerns the gene CD276 and ovarian carcinoma.